{"id":143078,"date":"2023-03-01T07:24:46","date_gmt":"2023-03-01T12:24:46","guid":{"rendered":"https:\/\/44.250.171.167\/?p=143078"},"modified":"2023-03-01T07:24:48","modified_gmt":"2023-03-01T12:24:48","slug":"laurus-labs-q3fy23-net-profit-rises-by-32-percent","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/laurus-labs-q3fy23-net-profit-rises-by-32-percent\/","title":{"rendered":"Laurus Labs Q3FY23 net profit rises by 32 percent"},"content":{"rendered":"\n<p>Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for the quarter ended December 31, 2022. The company had reported a net profit of INR 155 crore in the same quarter, previous fiscal year.<\/p>\n\n\n\n<p>The company&#8217;s consolidated revenue from operations for Q3FY23 came in at about INR 1,544.82 crore, up 50.16% YoY, whereas total expenses stood at INR 1,268.4 crore, recording an increase of 52.7% YoY. The company also spent INR 153 crore on R&amp;D in 9M FY23. Laurus Labs&#8217; EBITDA improved to INR 404 crore in Q3FY23, recording 39% YoY growth. The EBITDA margin stood at 26.1% in the quarter. Its EPS for the period stood at INR 3.7 per share.<\/p>\n\n\n\n<p>\u201cOur Q3 and 9M of 2023 results reflect sustained business momentum across our key growth drivers, which is visible in our commercial execution within CDMO, and Non-ARVs generic portfolio. Growth is also supported by anticipated recovery in the ARV FDF segment, which is likely to continue despite pricing challenges. We also made additional advancements in our R&amp;D initiatives and brought new capacities online,&#8221; said Satyanarayana Chava, Founder &amp; CEO of Laurus Labs.<\/p>\n\n\n\n<p>Its API business revenue reported INR 632 crore during Q3, which increased 49% YoY. Other APIs also saw strong growth at 33%, following a ramp-up in the new contract supplies. However, FDF revenues for the quarter declined 33% to INR 249 crore. Growth is impacted by lower demand and adverse prices in the ARV formulations, the company said in a release.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmaceutical and biotechnology company Laurus Labs reported 32% year-on-year (YoY) rise in profit after tax to INR 203 crore for the quarter ended December 31, 2022. The company had reported a net profit of INR 155 crore in the same quarter, previous fiscal year. The company&#8217;s consolidated revenue from operations for Q3FY23 came in at [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":27118,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5753],"tags":[10304,11463,9138],"class_list":["post-143078","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-industrials","tag-api","tag-biotech-pharma","tag-pharma"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":140654,"url":"https:\/\/alphastreet.com\/india\/tata-chemicals-reported-a-26-rise-in-its-net-profit-in-q3fy23\/","url_meta":{"origin":143078,"position":0},"title":"Tata chemicals reported a 26% rise in its net profit in Q3FY23","author":"Chirag Gupta","date":"February 9, 2023","format":false,"excerpt":"Tata Chemicals reported a 25.72% year-on-year (YoY) rise in its net profit to INR 391 crore for the quarter ended December 31, 2022. The company had reported a profit of INR 311 crore in the same quarter of the previous fiscal year. The company clocked a 32% increase in the\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":141349,"url":"https:\/\/alphastreet.com\/india\/vinati-organics-q3fy23-net-profit-soars-by-51\/","url_meta":{"origin":143078,"position":1},"title":"Vinati organics Q3FY23 net profit soars by 51%","author":"Chirag Gupta","date":"February 13, 2023","format":false,"excerpt":"Vinati Organics rose 1.55% to INR 1,895 after the company's consolidated net profit surged 50.68% to INR 125.41 crore in Q3 FY23 as against INR 83.23 crore posted in Q3 FY22. Revenue from operations stood at INR 508.66 crore in the quarter ended 31 December 2022 from INR 368.95 crore\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":143082,"url":"https:\/\/alphastreet.com\/india\/earnings-kalpataru-power-transmission-ltd-nsekalpatpowr-q3fy23-results-out-total-income-rise-2-yoy\/","url_meta":{"origin":143078,"position":2},"title":"Earnings | Kalpataru Power Transmission Ltd. (NSE:KALPATPOWR): Q3FY23 Results Out; Total Income rise 2% YoY","author":"Divyansh_Kasana","date":"March 1, 2023","format":false,"excerpt":"Kalpataru Power Transmission Ltd. (NSE:KALPATPOWR) is an Indian engineering, procurement, and construction (EPC) company that specializes in power transmission and distribution, oil and gas pipelines, railways, and infrastructure projects. The company was founded in 1981 and is headquartered in Mumbai, India. KPTL operates in more than 50 countries globally, with\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":142923,"url":"https:\/\/alphastreet.com\/india\/sanofi-india-limited-q3fy23-earnings-story\/","url_meta":{"origin":143078,"position":3},"title":"Sanofi India Limited Q3FY23 Earnings Story","author":"Karan_Singh","date":"February 27, 2023","format":false,"excerpt":"Sanofi India primarily deals with the Manufacture and sale of pharmaceutical products. Financial Results: The company reported a decline of 2.32% YoY in revenue from operations which stood at INR 671.9 crore in the third quarter of FY23, as compared to INR 687.90 crore in the year-ago quarter. In the\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/nutritional-supplement-2358477_1280-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":142206,"url":"https:\/\/alphastreet.com\/india\/poly-medicure-limited-q3fy23-earnings-story\/","url_meta":{"origin":143078,"position":4},"title":"Poly Medicure Limited Q3FY23 Earnings Story","author":"Karan_Singh","date":"February 17, 2023","format":false,"excerpt":"Poly Medicure Limited is an Indian company that deals with the manufacturing and exporting of medical devices. Some of its exported products include plastic medical surgical\/disposable devices. Financial Results: The company reported a 44.9 percent increase in net profit which stood at INR 50.01 crore. This was primarily due to\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/01\/iStock-1345489729.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":142228,"url":"https:\/\/alphastreet.com\/india\/polyplex-corp-limited-q3fy23-earnings-story\/","url_meta":{"origin":143078,"position":5},"title":"Polyplex Corp Limited Q3FY23 Earnings Story","author":"Karan_Singh","date":"February 17, 2023","format":false,"excerpt":"Polyplex Corporation primarily deals with the manufacturing of Blown PP\/PE, BOPP, and CPP films which are used in the flexible packaging industry. These also have industrial usages like labels, tapes, release liners, etc. The company has 33 years of experience in the Plastic Films industry.\u00a0 Financial Results: In the third\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/skyscrapers-7558938_1920-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/skyscrapers-7558938_1920-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/skyscrapers-7558938_1920-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/skyscrapers-7558938_1920-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=143078"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/143078\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/27118"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=143078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=143078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=143078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}